logo
Print

Differences in Outcomes Between Early and Late Diagnosis of Cystic Fibrosis in the Newborn Screening Era

    loading  Checking for direct PDF access through Ovid

Abstract

(ed from J Pediatr 2017;181:137–145)

Cystic fibrosis (CF) affects 1 in 3000 newborns in white populations and is a recessive disorder caused by mutations in the CFTR (CF transmembrane conductance regulator) gene. Newborn screening (NBS) for this disorder is common in developed countries and in New South Wales where this study was conducted NBS has been available since July 1981.

Related Topics

    loading  Loading Related Articles

Join Ovid Insights!

Benefits of Ovid Insights Include:

  • Consolidated email digests of the latest research in your favorite topics
  • A personalized dashboard of your topics all on one page 
  • Tools to bookmark and share articles of interest
  • Ability to customize and save your own searches

Register with Ovid Insights »